Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A Phase 1 Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib or Venetoclax in Participants with Relapsed/Refractory Hemato… Ended

2022-502672-23-00 Richter's Syndrome 2023-10-18
A study to investigate JNJ-80202135 (nipocalimab) delivered subcutaneously via prefilled syringe autoinjector and via normal syringe Ended

2023-504280-16-00 Healthy Volunteers 2023-10-17
A study to investigate the safety, tolerability, pharmacokinetics, and early signs of biological activity of danegaptide following oral admi… Ended

2023-503683-16-00 Diabetic macular edema 2023-10-16
Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects Ended

2023-506633-30-00 N/A submitted trial is conducted on healthy subjects 2023-10-13
MK-3508 Multiple Ascending Dose Study in Healthy Participants Ended

2023-505821-15-00 Respiratory syncytial virus infection 2023-10-12
Randomized, open-label, single dose, three-period, three treatment cross-over bioavailability study comparing test products Rosuvastatin/Eze… Ended

2023-507048-35-00 not applicable (submitted trial is bioavailability stud 2023-10-11
A Phase 1 Study to Assess Mass Balance, Pharmacokinetics, and Metabolism of [14C]Subasumstat in Patients With Advanced or Metastatic Solid T… Ended

2023-503449-79-00 Advanced or Metastatic Solid Tumours 2023-10-10
A study to investigate the effects of multiple doses of obefazimod on a combined oral contraceptive (ethinyl estradiol/drospirenone) in hea… Ended

2023-505297-15-00 Healthy female participants of childbearing potential. 2023-10-10
A clinical trial to learn how an investigational drug (norucholic acid) is absorbed, distributed, broken down, and removed from the body whe… Ended

2023-505862-27-00 Nonalcoholic fatty liver disease (NAFLD) 2023-10-10
A Phase I study to evaluate the pharmacokinetics, safety, and tolerability of multiple oral doses of obefazimod in patients with mild and mo… Ended

2023-505299-31-00 Ulcerative colitis and rheumatoid a1thritis 2023-10-09
A Study About Fazirsiran in People With and Without Liver Problems. Ended

2023-503735-17-00 Hepatic impairment. 2023-10-05
A Trial Investigating the pain-relieving properties of Lu AG06474 in Healthy Adult Participants Ended

2023-503987-18-00 Pain 2023-10-03
Investigation of safety, tolerability and pharmacokinetics of multiple doses of NNC0113‑6856 in healthy participants, including a subset of … Ended

2023-503891-26-00 Type 2 diabetes 2023-09-29
A clinical trial to evaluate the absolute bioavailability and metabolic profile of aticaprant when administered as an oral tablet and a micr… Ended

2022-502969-19-00 Healthy Adult Participants 2023-09-27
Open label, single-center, cross-over randomized, relative bioavailability study comparing 4 new BF2.649 (pitolisant) tablet formulations ve… Ended

2023-505769-98-00 Narcolepsy 2023-09-26
PET study of changes in [11C]AZ14132516 uptake following administration of AZD7798 to healthy participants and patients with Crohn’s disease Ended

2023-505471-78-00 Crohn's Disease 2023-09-25
A study to learn about how much elinzanetant gets absorbed in the blood and how safe it is in healthy participants when taken as different t… Ended

2023-503968-16-00 Vasomotor symptoms as a sex hormone-dependent disorder 2023-09-25
A Phase 1, Open-label, Pharmacokinetic Study of TVB-2640 in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects … Ended

2023-505180-36-00 Impaired Hepatic Function The study will enroll as fol 2023-09-21
A study to learn how much elinzanetant gets into the blood, how safe it is and how it affects the body after taking single and multiple amou… Ended

2023-503864-17-00 Vasomotor Symptoms as a sex hormone-dependent disorder 2023-09-20
A Pilot Open-label, Randomized, Crossover, Comparative Bioavailability Study of Levodopa Administered via Levodopa Cyclops™ (test product) R… Ended

2023-504687-42-00 No therapeutic indication in the current trial with hea 2023-09-19
A Phase 1 Study of BMS-986360/CC-90001 Alone and in Combination with Chemotherapy or Nivolumab in Advanced Solid Tumors Ended

2022-500930-27-00 Solid Tumor 2023-09-15
A Translational Phase 1B, 2-Part Study to Evaluate Pharmacokinetics, Safety and Pharmacodynamics of Treatment with ATX-304 Na Salt Tablets. Ended

2023-505967-36-00 Obesity with prediabetes or type 2 diabetes mellitus 2023-09-15
Open label study to investigate patch adhesion of an Esflurbiprofen-containing patch in healthy volunteers Ended

2023-503609-12-00 patch adhesion trial with healthy subjects, therapeutic 2023-09-14
A randomized, open-label, single dose, cross-over bioavailability study evaluating the drug-drug interaction between Tritace 10, 10 mg, tabl… Ended

2023-505887-12-00 NA - study in healthy subjects 2023-09-13